Fax: (216) 444-8685
Informing patients with cancer of ‘new findings’ that may influence their willingness to participate in research studies
Article first published online: 11 JUL 2003
Copyright © 2003 American Cancer Society
Volume 98, Issue 5, pages 885–887, 1 September 2003
How to Cite
Markman, M. (2003), Informing patients with cancer of ‘new findings’ that may influence their willingness to participate in research studies. Cancer, 98: 885–887. doi: 10.1002/cncr.11607
- Issue published online: 20 AUG 2003
- Article first published online: 11 JUL 2003
- Manuscript Accepted: 30 MAY 2003
- Manuscript Received: 27 MAY 2003
- 2Federal policy for the protection of human subjects. Final rule. Fed Regist. 1991; 56: 28003–28018 [codified in: Department of Health and Human Services. Code of federal regulations. Title 45, Section 46].
- 3A randomized Phase III trial of three versus six cycles of carboplatin and paclitaxel as adjuvant treatment in early stage ovarian epithelial carcinoma: a Gynecologic Oncology Group study [abstract]. Gynecol Oncol. 2003; 88: 156., , , et al.
- 6International Collaborative Ovarian Neoplasm Trial 1 and Adjuvant ChemoTherapy in Ovarian Neoplasm trial: two parallel randomized Phase III trials of adjuvant chemotherapy in patients with early-stage ovarian carcinoma. J Natl Cancer Inst. 2003; 95: 105–112., , , et al.
- 7Randomized trial comparing six versus three cycles of epirubicin-based adjuvant chemotherapy in premenopausal, node-positive breast cancer patients: 10-year follow-up results of the French Adjuvant Study Group 01 trial. J Clin Oncol. 2003; 21: 298–305., , , et al.